Pharsight

THE BROAD INSTITUTE PATENTS FACING OPPOSITIONS

Top patents of THE BROAD INSTITUTE facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2931897B1 01 Nov, 2017 Delivery, Engineering And Optimization Of Systems, Methods And Compositions For Sequence Manipulation And Therapeutic Applications NA 7
EP2825654B1 26 Apr, 2017 Crispr-Cas Component Systems, Methods And Compositions For Sequence Manipulation NA 7
EP3252160B1 28 Oct, 2020 Crispr-Cas Component Systems, Methods And Compositions For Sequence Manipulation NA 5
EP3502253B1 27 May, 2020 Novel Crispr Enzymes And Systems NA 4
EP3470519B1 12 Feb, 2020 Novel Crispr Enzymes And Systems NA 4
EP3310917B1 12 Feb, 2020 Novel Crispr Enzymes And Systems NA 4
EP3494997B1 18 Sep, 2019 Inducible Dna Binding Proteins And Genome Perturbation Tools And Applications Thereof NA 4
EP2940140B1 27 Mar, 2019 Engineering Of Systems, Methods And Optimized Guide Compositions For Sequence Manipulation NA 4
EP3327127B1 24 Mar, 2021 Delivery, Engineering And Optimization Of Systems, Methods And Compositions For Sequence Manipulation And Therapeutic Applications NA 3
EP3009511B2 27 Jan, 2021 Novel Crispr Enzymes And Systems NA 3
EP3144390B1 18 Mar, 2020 Engineering Of Systems, Methods And Optimized Guide Compositions For Sequence Manipulation NA 3
EP3064585B1 05 Feb, 2020 Engineering And Optimization Of Improved Systems, Methods And Enzyme Compositions For Sequence Manipulation NA 3
EP2931892B1 12 Sep, 2018 Methods, Models, Systems, And Apparatus For Identifying Target Sequences For Cas Enzymes Or Crispr-Cas Systems For Target Sequences And Conveying Results Thereof NA 3
EP3237615B2 26 Jul, 2023 Crispr Having Or Associated With Destabilization Domains NA 2
EP3011031B1 30 Sep, 2020 Delivery And Use Of The Crispr-Cas Systems, Vectors And Compositions For Hepatic Targeting And Therapy NA 2
EP3011032B1 16 Oct, 2019 Delivery, Engineering And Optimization Of Systems, Methods And Compositions For Targeting And Modeling Diseases And Disorders Of Post Mitotic Cells NA 2
EP3551753B1 29 Jun, 2022 Crispr Effector System Based Diagnostics NA 1
EP2668294B1 07 Apr, 2021 Paired End Bead Amplification And High Throughput Sequencing NA 1
EP3011034B1 07 Aug, 2019 Delivery, Use And Therapeutic Applications Of The Crispr-Cas Systems And Compositions For Targeting Disorders And Diseases Using Viral Components NA 1